サンプル依頼リスト カート
  • English
  • Korean
表紙：末梢動脈疾患（PAD）の世界市場レポート 2024年
市場調査レポート
商品コード
1415746

末梢動脈疾患（PAD）の世界市場レポート 2024年

Peripheral Arterial Disease Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
末梢動脈疾患（PAD）の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

末梢動脈疾患の市場規模は近年力強く成長しています。2023年の40億米ドルから2024年には43億6,000万米ドルへと、CAGR9.1％で拡大します。実績期間の成長は、革新的な医療機器、遺伝子治療と再生医療、薬理ゲノミクス、デジタルヘルス、遠隔モニタリングに起因しています。

末梢動脈疾患市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR8.5％で60億5,000万米ドルに成長します。予測期間の成長は、学際的ケアチーム、低侵襲的介入、ライフスタイルや運動処方に起因しています。予測期間中の主な動向には、血管遠隔リハビリテーション、マルチモーダル疼痛管理、創傷ケアの進歩、公衆衛生キャンペーンなどがあります。

心疾患の罹患率の増加は、今後数年間の末梢動脈疾患市場成長の重要な促進要因になると予想されます。一般的な心臓疾患は、心筋に血液を供給する主要な血管に影響を及ぼします。末梢動脈疾患治療は、血流を改善し、心血管系のリスクを軽減し、症状を緩和し、最終的に全体的な生活の質を高めることによって、心臓病患者を支援する上で重要な役割を果たしています。例えば、2023年6月、米国の政府機関である疾病管理予防センターは、2021年に心血管疾患に起因する死亡者数が695,547人に達したと報告しました。さらに、2022年4月の時点で、米国を拠点とする非営利の医学団体である米国心臓病学会は、虚血性心疾患の危険因子が30.7％増加し、2025年までに2900万症例に達すると予測しています。したがって、心疾患の有病率の増加は、末梢動脈疾患市場の重要な原動力となっています。

糖尿病の有病率の増加は、当面の末梢動脈疾患市場成長の重要な原動力になると考えられます。糖尿病は、血糖値の上昇を特徴とする慢性代謝疾患であり、世界的に増加傾向にあります。糖尿病の有病率の増加に伴い、この病態に対処する治療薬に対する需要も並行して急増しています。この急増は、末梢動脈疾患（PAD）に関連して特に顕著です。糖尿病患者は、PADの主な原因である動脈硬化を発症するリスクが高く、治療が必要です。例えば、ベルギーを拠点とする糖尿病団体である国際糖尿病連合（IDF）は、2021年7月の時点で、世界の糖尿病人口は2021年に5億3,700万人、2030年に6億4,300万人、2045年に7億8,300万人に達すると予測しています。さらに、2021年までに5億4,100万人が耐糖能障害を経験すると推定されました。さらに、2021年には20歳から79歳までの約670万人が糖尿病に関連する合併症で死亡すると予測されました。したがって、糖尿病有病率の上昇は、末梢動脈疾患市場成長の重要な原動力となっています。

2023年の末梢動脈疾患市場では北米が最大地域でした。末梢動脈疾患レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の末梢動脈疾患市場、治療タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • デバイス
  • カテーテル
  • 薬物
  • その他
  • 世界の末梢動脈疾患市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • オーラル
  • 非経口
  • その他
  • 世界の末梢動脈疾患市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 専門クリニック
  • その他

第7章 地域および国の分析

  • 世界の末梢動脈疾患市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の末梢動脈疾患市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 末梢動脈疾患市場の競合情勢
  • 末梢動脈疾患市場の企業プロファイル
    • Cardinal Health Inc.
    • Johnson and Johnson Limited
    • Abbott Laboratories
    • Medtronic Plc
    • Becton Dickinson and Company

第31章 その他の主要および革新的な企業

  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • B. Braun SE
  • Terumo Corp.
  • Cook Medical LLC
  • Penumbra Inc.
  • Shockwave Medical Inc.
  • AngioDynamics Inc.
  • Cardiovascular Systems Inc.
  • ACIST Medical Systems Inc.
  • SurModics Inc.
  • Endologix Inc.
  • BioVentrix Inc.
  • QT Vascular Ltd.
  • Avinger Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12345

“Peripheral Arterial Disease Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peripheral arterial disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peripheral arterial disease? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The peripheral arterial disease market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Treatment Type: Devices; Catheters; Drugs; Other Types
  • 2) By Route of Administration: Oral; Parenteral; Other Route of Administrations
  • 3) By End User: Hospitals; Specialty Clinics; Others End-Users
  • Companies Mentioned: Cardinal Health Inc.; Johnson and Johnson Limited; Abbott Laboratories; Medtronic Plc; Becton Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Peripheral Arterial Disease (PAD) is a medical condition characterized by the narrowing or obstruction of arteries, primarily those supplying blood to the legs and feet. This condition is a type of atherosclerosis, where fat deposits (plaque) accumulate in the arteries, leading to diminished blood flow. The treatment of PAD typically involves a multifaceted approach, incorporating lifestyle adjustments, medication regimens, and medical procedures. The objective is to augment blood supply to the affected extremities, alleviate symptoms, and mitigate associated risks.

The primary treatment modalities for Peripheral Arterial Disease encompass devices, catheters, drugs, and other interventions. Devices for PAD pertain to specialized medical tools employed in the diagnosis, treatment, and management of the condition. These treatments can be administered through various routes, including oral, parenteral, and others. They find application across a spectrum of end-users, such as hospitals, specialty clinics, and other healthcare facilities.

The peripheral artery disease market research report is one of a series of new reports from The Business Research Company that provides peripheral artery disease market statistics, including peripheral artery disease industry global market size, regional shares, competitors with a peripheral artery disease market share, detailed peripheral artery disease market segments, market trends and opportunities and any further data you may need to thrive in the peripheral artery disease industry. This peripheral artery disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peripheral arterial disease market size has grown strongly in recent years. It will grow from $4 billion in 2023 to $4.36 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to innovative medical devices, gene therapy and regenerative medicine, pharmacogenomics, digital health and remote monitoring.

The peripheral arterial disease market size is expected to see strong growth in the next few years. It will grow to $6.05 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to interdisciplinary care teams, minimally invasive interventions, lifestyle and exercise prescriptions. Major trends in the forecast period include vascular tele-rehabilitation, multimodal pain management, wound care advances, public health campaigns.

The increasing incidence of cardiac diseases is expected to be a significant driver for the growth of the peripheral arterial disease market in the coming years. Cardiac disease, a common heart condition, affects the main blood vessels supplying blood to the heart muscle. Peripheral arterial disease treatment plays a crucial role in aiding cardiac patients by improving blood flow, reducing cardiovascular risks, alleviating symptoms, and ultimately enhancing their overall quality of life. For instance, in June 2023, the Center for Disease Control and Prevention, a US-based government agency, reported that the number of deaths attributed to cardiovascular diseases had reached 695,547 in 2021. Additionally, as of April 2022, the American College of Cardiology, a US-based non-profit medical association, predicted a 30.7% increase in the risk factors for ischemic heart disease, with an estimated 29 million cases by 2025. Therefore, the growing prevalence of cardiac diseases acts as a significant driving force for the peripheral arterial disease market.

The increasing prevalence of diabetes is poised to be a significant driver for the growth of the peripheral arterial disease market in the foreseeable future. Diabetes, a chronic metabolic condition characterized by elevated blood glucose levels, is on the rise globally. With the growing prevalence of diabetes, there is a parallel surge in the demand for treatments addressing this condition. This surge is particularly notable in relation to peripheral arterial disease (PAD). Individuals with diabetes face an elevated risk of developing atherosclerosis, which is the primary cause of PAD and necessitates treatment. For instance, as of July 2021, the International Diabetes Federation (IDF), a Belgium-based diabetes organization, projected that the global population with diabetes would reach 537 million in 2021, 643 million in 2030, and 783 million in 2045. Additionally, it was estimated that 541 million people would experience impaired glucose tolerance by 2021. Furthermore, it was anticipated that nearly 6.7 million individuals between the ages of 20 and 79 would succumb to complications related to diabetes in 2021. Therefore, the escalating prevalence of diabetes stands as a significant driving force for the growth of the peripheral arterial disease market.

The insufficiency of healthcare infrastructure is anticipated to impede the growth of the peripheral arterial disease market. A dearth of accessible healthcare services can pose significant challenges for patients in obtaining the necessary drugs and treatments, especially in developing economies where resources and infrastructure may be limited. For instance, as of June 2023, the National Rural Health Alliance, a non-profit organization based in Australia, reported that over 7 million individuals, which constitutes over a third of Australia's population, bear a disproportionate burden of illness and premature mortality, partly due to inadequate healthcare spending. This indicates a significant gap in healthcare infrastructure. Therefore, the deficiency in healthcare infrastructure stands as a substantial constraint on the growth of the peripheral arterial disease market.

Prominent companies in the peripheral arterial disease market are dedicated to the development of cutting-edge drugs and solutions to maintain their competitive edge. This emphasis on drug innovation holds the potential to yield more effective treatments for PAD, ultimately reducing the risk of complications and enhancing patient outcomes. For instance, in August 2021, The Janssen Pharmaceutical Companies, a Belgium-based pharmaceutical firm, obtained an expanded indication for peripheral artery disease (PAD) for the XARELTO (rivaroxaban) dose from the Food and Drug Administration (FDA), a US-based government agency. Notably, XARELTO stands as the first and only therapy approved for both coronary artery disease (CAD) and PAD, including PAD patients post-LER (lower extremity revascularization). This medication is also recommended for patients dealing with acute limb ischemia and amputation, ischemic stroke, and myocardial infarction.

In February 2023, Abbott Laboratories, a prominent US-based pharmaceutical company, successfully completed its acquisition of Cardiovascular Systems Inc. for a total of $890 million. Through this strategic acquisition, Abbott intends to fortify its cardiovascular portfolio by integrating new and complementary technologies. Cardiovascular Systems Inc., based in the US, is a leading medical device company specializing in the development and commercialization of products tailored for the treatment of peripheral and coronary vascular disease.

Major players in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC .

North America was the largest region in the peripheral artery disease market in 2023. The regions covered in peripheral artery disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the peripheral artery disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peripheral artery disease market consists of sales of cardiac medical devices and diagnostic tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Peripheral Arterial Disease Market Characteristics

3. Peripheral Arterial Disease Market Trends And Strategies

4. Peripheral Arterial Disease Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Peripheral Arterial Disease Market Size and Growth

  • 5.1. Global Peripheral Arterial Disease Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Peripheral Arterial Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Peripheral Arterial Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Peripheral Arterial Disease Market Segmentation

  • 6.1. Global Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Devices
  • Catheters
  • Drugs
  • Other Types
  • 6.2. Global Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Route of Administrations
  • 6.3. Global Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Others End-Users

7. Peripheral Arterial Disease Market Regional And Country Analysis

  • 7.1. Global Peripheral Arterial Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Peripheral Arterial Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Peripheral Arterial Disease Market

  • 8.1. Asia-Pacific Peripheral Arterial Disease Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Peripheral Arterial Disease Market

  • 9.1. China Peripheral Arterial Disease Market Overview
  • 9.2. China Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Peripheral Arterial Disease Market

  • 10.1. India Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Peripheral Arterial Disease Market

  • 11.1. Japan Peripheral Arterial Disease Market Overview
  • 11.2. Japan Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Peripheral Arterial Disease Market

  • 12.1. Australia Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Peripheral Arterial Disease Market

  • 13.1. Indonesia Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Peripheral Arterial Disease Market

  • 14.1. South Korea Peripheral Arterial Disease Market Overview
  • 14.2. South Korea Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Peripheral Arterial Disease Market

  • 15.1. Western Europe Peripheral Arterial Disease Market Overview
  • 15.2. Western Europe Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Peripheral Arterial Disease Market

  • 16.1. UK Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Peripheral Arterial Disease Market

  • 17.1. Germany Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Peripheral Arterial Disease Market

  • 18.1. France Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Peripheral Arterial Disease Market

  • 19.1. Italy Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Peripheral Arterial Disease Market

  • 20.1. Spain Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Peripheral Arterial Disease Market

  • 21.1. Eastern Europe Peripheral Arterial Disease Market Overview
  • 21.2. Eastern Europe Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Peripheral Arterial Disease Market

  • 22.1. Russia Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Peripheral Arterial Disease Market

  • 23.1. North America Peripheral Arterial Disease Market Overview
  • 23.2. North America Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Peripheral Arterial Disease Market

  • 24.1. USA Peripheral Arterial Disease Market Overview
  • 24.2. USA Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Peripheral Arterial Disease Market

  • 25.1. Canada Peripheral Arterial Disease Market Overview
  • 25.2. Canada Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Peripheral Arterial Disease Market

  • 26.1. South America Peripheral Arterial Disease Market Overview
  • 26.2. South America Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Peripheral Arterial Disease Market

  • 27.1. Brazil Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Peripheral Arterial Disease Market

  • 28.1. Middle East Peripheral Arterial Disease Market Overview
  • 28.2. Middle East Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Peripheral Arterial Disease Market

  • 29.1. Africa Peripheral Arterial Disease Market Overview
  • 29.2. Africa Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Peripheral Arterial Disease Market Competitive Landscape And Company Profiles

  • 30.1. Peripheral Arterial Disease Market Competitive Landscape
  • 30.2. Peripheral Arterial Disease Market Company Profiles
    • 30.2.1. Cardinal Health Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson Limited
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Medtronic Plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton Dickinson and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Peripheral Arterial Disease Market Other Major And Innovative Companies

  • 31.1. Koninklijke Philips N.V.
  • 31.2. Boston Scientific Corporation
  • 31.3. B. Braun SE
  • 31.4. Terumo Corp.
  • 31.5. Cook Medical LLC
  • 31.6. Penumbra Inc.
  • 31.7. Shockwave Medical Inc.
  • 31.8. AngioDynamics Inc.
  • 31.9. Cardiovascular Systems Inc.
  • 31.10. ACIST Medical Systems Inc.
  • 31.11. SurModics Inc.
  • 31.12. Endologix Inc.
  • 31.13. BioVentrix Inc.
  • 31.14. QT Vascular Ltd.
  • 31.15. Avinger Inc.

32. Global Peripheral Arterial Disease Market Competitive Benchmarking

33. Global Peripheral Arterial Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Peripheral Arterial Disease Market

35. Peripheral Arterial Disease Market Future Outlook and Potential Analysis

  • 35.1 Peripheral Arterial Disease Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Peripheral Arterial Disease Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Peripheral Arterial Disease Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer